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Polyethylene micro;sized wear particles released from orthopaedic implants promote 
inflammation and osteolysis; however, less is known about the bioactivity of polyethylene nano;
sized wear particles released from the last generation of polymer;bearing surfaces. We aim to 
assess the internalization of fluorescent polyethylene;like nanoparticles by both human 
macrophages and osteoclasts and also, to determine their effects in osteoclastogenesis  . 
Human macrophages and osteoclasts were incubated with several ratios of fluorescent 
polyethylene;like nanoparticles between 1;72 hours, and 4 hours, 2, 4, 6 and 9 days respectively. 
The internalization of nanoparticles was quantified by flow cytometry and followed by both 
confocal and video time;lapse microscopy. Osteoclast differentiation and activity was semi;
quantified by Tartrate;Resistant Acid Phosphatase (TRAP) staining, TRAP mRNA relative 
expression and pit resorption assay respectively. Macrophages, osteoclast precursors and mature 
osteoclasts internalized nanoparticles in a dose; and time;dependent manner and maintained their 
resorptive activity. In addition, nanoparticles significantly increased the osteoclastogenesis as 
shown by up;regulation of the TRAP expressing
 
cell number. We conclude that polyethylene;like 
nano;sized wear particles promote osteoclast differentiation without alteration of bone resorptive 
activity of mature osteoclasts and they could be considered as important actors in periprosthetic 
osteolysis of the last new generation of polymer;bearing surfaces. 
 
 !"#$: Aseptic loosening; Polyethylene; Nanoparticles; Macrophages, Osteoclasts.  
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Wear particles released from classic polyethylene surfaces of prosthetic joints constitute the main 
activator of periprosthetic inflammation and osteolysis leading to aseptic loosening of 
orthopaedic implants 
(1)
. It is admitted that the biological interactions underlying this process are 
based on the internalization of polyethylene micro;sized wear particles by macrophages with 
their subsequent activation 
(2)
. Consequently, local activated macrophages guide to the 
recruitment of systemic monocyte;macrophage precursors, leading to the development of a 
chronically inflamed periprosthetic bone niche and promoting the differentiation of their 
precursors toward bone resorbing osteoclasts 
(3)
 (Figure #1 in Supplementary data).  
 
In the last 15 years, cross;linked polyethylene, an optimized high;density polyethylene, has been 
widely used in clinics, improving the clinical behavior of prosthetic joints assessed for up to 10 
years 
(4)
. Recent reports based on the long;term follow;up of those prosthesis and joint 
simulators, describe the presence of significant amount of nano;sized wear particles released 
from cross;linked polyethylene bearing surfaces 
(5)–(9)
. Importantly, these nano;sized wear 
particles have been reported more bioactive than micro;sized ones when they stimulate clinically 
relevant cell cultures 
(7),(8)
. Nevertheless, the internalization of polyethylene nanoparticles by the 
monocyte;macrophage;osteoclast lineage and their functional effects on the same cells remain 
poorly understood. The aim of this study was to assess the internalization of fluorescent 
polyethylene;like nanoparticles (FPN) by monocyte;macrophage;osteoclast lineage and 
determine their effect in osteoclastogenesis .  
 
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To address our aim we firstly, incubated macrophages, pre;osteoclasts and osteoclasts with 
specific ratios of customized fluorescent polyethylene;like nanoparticles (described below) per 
cell at specific time points and then, we assessed their internalization by both fluorescence 
activated cell;sorting (FACS) and high resolution microscopy methods. Secondly, we quantified 
the effect of fluorescent polymeric nanoparticles on the osteoclast differentiation by quantifying 
the expression of Tartrate;Resistant Acid Phosphatase (TRAP).

		
Aqueous suspensions of fluorescent polyethylene;like nanoparticles (FPN) were obtained from 
the stiff self;assembling of oligoethylene chains (20 carbon atoms) functionalized with orange;
red;emitting fluorophores, and characterized according to Faucon, . (2013) 
(10)
 (Figure #2 in 
Supplementary data). Such FPN contain fluorophores similar to those already exploited as 
fluorescent and magnetofluorescent nanoparticles to perform  imaging 
(11)
 and  
magnetic resonance imaging (MRI) 
(12)
, respectively. In those cases, cell viability assays showed 
no detectable cytotoxicity, confirming the biocompatibility of the fluorescent material while 
strong emissive signal could be observed inside the cells after internalization with no trace of 
excreted fluorescence over the long term. The mean hydrodynamic diameter H was measured to 
be 169 ± 77 nm by dynamic light scattering (DLS). The colloidal suspension of nanoparticles 
revealed stable in physiological culture media due to the highly charged surface potential found 
at ;50 mV upon zetametry mesurements. The emission spectrum was centered at λmax(em) = 580 
nm after exciting at 488 nm, which limits the contribution of autofluorescence. The absence of 
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endotoxin was confirmed using a quantitative Limulus Amebocyte Lysate (LAL) assay (Lonza, 
Belgium) with a threshold of positivity of 0.25 EU/mL.

		
 
!
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Ethical approval for the use of peripheral blood from healthy donors was obtained from the 
Nantes University Hospital Ethics Committee. Samples were obtained from the ‘‘Etablissement 
Français du Sang’’ with informed consent (agreement reference NTS 2000;24,190 Avenant 
n°10). Peripheral blood mononuclear cells (PBMC) from seven healthy donors (age= 49.14; 
range 24;63) were isolated by centrifugation over Ficoll gradient (Sigma, Saint Quentin;
Fallavier, France). CD14
+ cells were magnetically labeled with CD14 microbeads and positively 
selected by MACS technology (Miltenyi Biotec, Bergisch Gladbach, Germany). Selected CD14
+
 
cells were analyzed by flow cytometry with a purity of ≥ 95% and the detection of 5%;10% of 
the CD14
+ CD16
+ non;classical monocytes. Isolated cells were frozen prior to further 
experiments. All assays were performed with n=3;5 for each condition and representative of at 
least two independent experiments. 

	 	"
1.5 x 10
6
 human blood;derived CD14
+
 monocytes were seeded in 6;well plate and cultured for 3 
days in 2 ml of minimum essential medium alpha (MEM;α, Lonza, Belgium) supplemented with 
10% foetal bovine serum (FBS, Ozyme, France), 1% of antibiotics and supplemented with 25 
ng/mL of human macrophage colony stimulating factor (hM;CSF, R&D systems, Abingdon, UK) 
(macrophage growth media). Then, adherent CD14
+
 cells were cultured in macrophage media as 
naive macrophages and incubated with three different ratios of FPN per cell during 1, 4, 8, 12, 
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24, 48 and 72 hours. The three ratios of FPN were theoretically calculated from the stock solution 
concentration (4 x 10
10
 FPN/mL) and diluting in culture media accordingly. They are 2 x 10
3
 
FPN per cell (baseline equivalent with 2 x 10
9
 FPN/mL), 4 X 10
3
 FPN per cell (equivalent with 4 
x 10
9
 FPN/mL) and 8 x10
3
 FPN per cell (equivalent with 8 x 10
9
 FPN/mL).  
 
	#	$%&'
4.5 x 10
3
 and 1.5 x 10
6
 human blood;derived CD14
+ 
cells were seeded in 96; and 6;well plates 
respectively as described 
(13),(14)
 and then cultured for 72 hours in macrophage growth media. 
Then, adherent cells were cultured in macrophage growth media supplemented with 100 ng/ml of 
human Receptor Activator of Nuclear factor Kappa;B Ligand (hRANKL) (osteoclast 
differentiation media [ODM]) for up to 11 days (endpoint of osteoclastogenesis). During the 
early period of culture in ODM (day 2), multinucleated cells with up to 3 nuclei were considered 
as osteoclast precursors and they were subsequently incubated with FPN for either 4 hours (at day 
2 of culture), 2 (corresponding to day 4 of culture), 4 (corresponding to day 6 of culture), 6 
(corresponding to day 8 of culture) and 9 (corresponding to day 11 of culture) days. 
Consequently, multinucleated cells containing more than 3 nuclei were considered as mature 
osteoclasts and were manually counted under a light microscope (Leica DM IRB, Nanterre, 
France) after TRAP staining (Sigma) at the endpoint of osteoclastogenesis (day 11 in ODM). 
Otherwise, 50 x 10
3
 CD14
+
 cells were cultured and differentiated into osteoclasts in 8;well plates 
(Millicell) using similar protocol focusing confocal microscopy and time;lapse video microscopy 
assessment.  

	(	&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
Osteoclast capacity for bone resorption was assessed by pit formation assay 
(15)
. For this purpose, 
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2 x 10
5 
CD14
+
 human blood;derived CD14
+ 
cells were differentiated into osteoclasts on 5 mm 
diameter dentin slices in 48well culture plates using the same protocol. At the end of the culture 
period (day 11), dentin slices were washed, and adherent osteoclasts and mononuclear cells were 
removed manually. Resorption pits were assessed qualitatively by scanning electron microscopy 
(TM3000, Hitachi, Krefeld, Germany). 


	)	*+
 
Adherent macrophages were enzymatically detached using Accutase® cell detachment solution 
(Life Technologies, Saint Aubin, France). The fluorescence emitted by FPN uptaken by 
macrophages was assessed by flow cytometry (FC500 Beckman Coulter,Inc. Brea, CA, US) and 
expressed as the fold change of relative ; mean fluorescent intensity (MFI); corresponding to the 
ratio between the MFI from FPN incubated macrophages over the MFI from control 
macrophages. Macrophage viability was assessed by DAPI staining on the LSR II Analyzer (BD 
Immunocytometry Systems, San Diego, CA), using Diva software (BD Immunocytometry 
Systems, San Diego, CA) for data analysis in the University of Nantes FACS Facility.   
 
	,	
Confocal images of fixed macrophages and osteoclasts stimulated with FPN were carried out 
using confocal microscopy (Nikon A1 RSi, Nikon, France). Excitation of FPN was performed 
with a 488 nm laser beam, while their emission was detected at 595/25 nm to identify their 
localization in both macrophage and osteoclast experiments. F;Actin of macrophage cytoskeleton 
was stained with phalloidin AlexaFluor546 (Life) whose excitation was performed with a 561 nm 
laser beam and the emission detected at 595/25 nm. Although the FPN and macrophage 
cytoskeleton emission signals could be fully be distinguished using distinct excitation 
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wavelengths, we privileged the use of the more red;shifted phalloidin AlexaFluor647 (Life) that 
was excited with a 633 nm laser beam, and its emission detected at 700/38 nm to warrantee the 
clear recognition of both independent fluorescent signals. Nuclei were stained with 
DAPI  (Invitrogen) (excitation with a 405 nm laser beam and emission selected at 450/25 nm in 
macrophage and osteoclast experiments). The analysis of images was performed using the 
software Fiji (NIH, USA).

	-	%.
Consecutives images of macrophages and osteoclasts stimulated with FPN were acquired each 20 
and 10 minutes respectively for up 72 hours using light background fluorescence be means of a 
wide;field microscope (Leica DMI 6000B) (40x). Images were acquired and edited using 
Metamorph software (Molecular Devices®). 

	
/	&'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Total RNA was extracted from cultured cells of each group using homogenizer Ika Ultra;Thurax 
T 25 (Janke and Kunkel) and TRIzol reagent (Invitrogen). Synthesis of the first strand of 
complementary DNA and the polymerase chain reaction were carried out in triplicate using the 
same protocol as described above. The listed oligonucleotides were used to amplify TRAP (5’;
AAGACTCACTGGGTGGCTTTG;3’ and 3’;GGCAGTCATGGGAGTTCAGG;5’), GADPH 
(5’;TGGGTGTGAACCATGAGAAGTATG;3’ and 3’;GGTGCAGGAGGCATTGCT;5) and 
B2M 1#2.TTCTGGCCTGGAGGCTATC;3’ and 3’; TCAGGAAATTTGACTTTCCATTC;5’) 
were used as housekeeping genes. Analyses were performed using the Vandesompele method 
(16)
.


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Results are given as mean ± standard deviation (SD). Unpaired t;test was used to analyse the 
difference between two groups (MFI fold change in macrophage internalization assays and TRAP 
fold change). Multiple comparisons were assessed by one;way ANOVA followed by Dunnett’s 
test (number of TRAP
+
 cells in osteoclastogenesis assays) to compare to the control group. In all 
cases, differences consider a p value < 0.05. All statistical tests were performed with Graphpad 
Prism Version 6.0e for Mac OS X (GraphPad Software, La Jolla, CA, USA). 
 
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We first analyzed the ability of cultured human macrophages to internalize nanoparticles by 
detecting their fluorescent intensity using flow cytometry. After 48 hours of incubation, FPN 
were internalized by macrophages in a dose dependent manner as shown by an increase of mean 
fluorescence intensities (MFI). The internalization of nanoparticles was then significantly up 
modulated by 2.1, 3.2 and 5.7;fold for the ratio 2 x 10
3
, 4 x 10
3
 and 8 x 10
3
 respectively  (Figure 
1A). Subsequently, to assess the viability of macrophages exposed to 4 x 10
3 
FPN per cell, we 
quantified the number of dead cells by flow cytometry. No significant increase in macrophage 
death was observed at 24 hours (8.2%) and 48 hours (6.1%) compared to the control group 
(7.7%) (Figure 1B).  Additionally, a kinetic study of CFPN internalization was also carried out, 
showing that macrophages internalize FPN from the first hour of exposition demonstrated by a 
time;dependent increase of MFI (1.5, 2.3, 3.3, 5.1 and 8.6;fold after 1, 4, 8, 12 and 24 hours of 
incubation with 4 x 10
3 
FPN respectively) (Figure 1C).  
 
To determine the location of FPN in macrophages and their impacts on cell morphology, we 
carried confocal microscopy acquisitions of consecutives stacked cell sections after 48 hours of 
cell incubation with nanoparticles. This microscopic analysis revealed two patterns of cell 
morphology were distinguished: a) highly adherent cells, which were characterized by an 
elongated shape with clustered intracellular FPN (Figure 1D), and b) low adherent cells with a 
rounded shape containing less amount of cytosolic nanoparticles (Figure 1E). Interestingly, in 
this later group, FPN were detected in both intracellular and extracellular compartments (Figure 
1E, upper left). All the internalized FPN were organized in rounded clusters of variable size 
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limited by a membrane;like edge, which were detected in a lateral or supra;nuclear position 
(Figure 1D, orthogonal views); others were identified near to the focal points (Figure 1D). To 
complete these observations, the internalization of FPN by macrophages was followed by time;
lapse microscopy on a 72 hours period (Video Time Lapse #1 in Supplementary Data). First 
internalization images of FPN were observed 20 minutes after the initial contact between cells 
and nanoparticles. This internalization took place at one pole of the cell followed by an 
intracellular trafficking and then, expulsion by a contra;lateral pole. Packed FPN were expulsed 
to the extracellular compartment 6 hours after the first contact with nanoparticles. Interestingly, 
this process induced the death of various macrophages (Video Time Lapse #1 in Supplementary 
Data). Our observations clearly demonstrated that human macrophages were able to internalize 
FPN in a dose; and time;dependent manner, followed by intracellular processing and packing 
with subsequent exocytosis of clustered bodies of FPN.      
 
On the other hand, the capacity of osteoclast precursors and mature osteoclasts to internalize FPN 
was then assessed by confocal microscopy after 4 hours and 9 days of incubation. Both osteoclast 
precursors and mature osteoclasts exposed for 4 hours to FPN exhibited high capacity to 
internalize nanoparticles (Figure 2A). After 4 hours of incubation, the fluorescence intensity of 
FPN in osteoclast precursors appeared stronger than in mature osteoclasts (Figure 2A). In 
addition, after 9 days of incubation, nanoparticles were always detectable inside mature 
osteoclasts, however the fluorescence of nanoparticles was heterogeneously distributed and more 
diffuse compared to the fluorescence detected after 4 hours of exposure (Figure 2A). The 
internalization ability of osteoclast was confirmed by time;lapse microscopy. Indeed, FPN were 
internalized by mature osteoclasts at 4 hours of incubation and by osteoclasts precursors after 10 
minutes (Video Time Lapse #2 in Supplementary Data). The osteoclasts morphology was then 
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modified after 9 days of incubation with FPN, exhibiting a rounded shape rather than a square 
one, as observed in the control cells (Figure 2B, upper). It is important to notice that the 
osteoclasts challenged with FPN maintained their resorptive function as revealed by a qualitative 
assessment of resorption pits on dentin slice (Figure 2B, bottom). 

		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To assess the effect of the amount of nanoparticles in osteoclastogenesis, osteoclast precursors 
were incubated with growing ratios of FPN per cell: 4 x 10
2
, 2 x 10
3
, 4 x 10
3
 and 8 x 10
3
. The 
number of multinucleated TRAP
+
 stained cells was determined after 9 days of culture (Figures 
3B and 3C). Whereas lower ratios of FPN per cell (4 x 10
2
 and 2 x 10
3
) did not modify the 
number of osteoclasts compared to the control group, higher ratios significantly increased their 
number compared to the untreated group (286 ± 73 osteoclasts for ratio 4 x 10
3
; 253 ± 74 
osteoclasts for ratio 4 x 10
3
  178 ± 41 osteoclasts for control; p<0.01 and p<0.05 
respectively) (Figure 2C, left). Similarly, the number of osteoclasts increased in a time;dependent 
manner after incubation with 4 x 10
3 
FPN per cell for at least 4 days (p<0.05) (Figure 2C, right). 
We then assessed the mRNA relative expression of TRAP by osteoclasts incubated with the same 
amount of FPN during 2 (d2), 6 (d6) and 9 (d9) days  (Figure 2D). We observed that TRAP 
expression was up;regulated by 0.5 fold for days 2 (p<0.0001) and 6 (p<0.001) and 1 fold for day 
9 (p<0.001) in osteoclasts exposed to FPN compared with osteoclasts non exposed to FPN (Ct). 
Finally, the osteoclasts challenged with FPN maintained their resorptive function as revealed by a 
qualitative assessment of resorption pits on dentin slice (Figure 2B, bottom).  
 
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The present study aimed to assess the internalization of polyethylene nanoparticles by monocyte;
macrophage;osteoclast lineage using FPN. In addition, the impact of FPN on osteoclastogenesis 
and osteoclast activity in the context of wear;particles induced osteolysis was analyzed. We 
demonstrated the intracellular uptake of FPN by both macrophages and osteoclasts promotes 
osteoclast differentiation. Despite to the reported inter;individual variability of the monocyte;
derived lineage response under different stimuli 
(17)
, our data underline an important role or FPN 
in the dysregulation of healthy human macrophages and osteoclasts . These findings could 
be associated with the pathophysiologic events of aseptic loosening of orthopaedic implants.
 
The study of the effect of polyethylene nano;sized wear particles on monocyte;macrophage;
osteoclast lineage response is a relevant topic in orthopaedic research. Indeed, previous studies 
demonstrated the effects of the size and composition of wear;particles on macrophage bioactivity 
(18),(19)
. Authors found, an inversed correlation between particle size and biological activity 
according with their volumetric concentration 
(18)
. With this regard, FPN used in our study 
constitute a relevant model of polyethylene nanoparticles by both their size (169 ± 77 nm) and 
their polymeric nature. In fact, these nanoparticles are in the size range of those retrieved from 
human periprosthetic tissues, reported as important promoter of periprosthetic chronic 
inflammation 
(5),(6),(9)
. Moreover, they polymeric composition by customization with long alkyl 
chains containing 20 carbon atoms and the high payload of up to 10
5
 closely packed molecules 
per nanoparticle, also gather the composition and density of retrieved polyethylene wear debris 
(5),(6),(9)
. Importantly, polymeric chains were reported acting as danger associated molecular 
patterns (DAMPs), being recognized by specific toll;like receptors (TLRs) in macrophages 
(17)
. 
The recognition of DAMPs by TLRs is an crucial step in the classical activation of naïve 
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macrophages to the pro;inflammatory phenotype 
(17)
. Finally, these nanoparticles are detectable 
and biocompatible by presenting fluorophores akin to those used in fluorescent and 
magnetofluorescent nanoparticles exploited for   
(11)
 and   MRI imaging 
(12)
. In 
those cases, cell viability assays showed no detectable cytotoxicity, confirming the 
biocompatibility of fluorescent organic nanoparticles while strong emissive signal could be 
observed inside the cells after internalization. Moreover, we established a culture system of 
macrophages and osteoclasts exposed to nanoparticles in suspension overcoming the technical 
limitations reported for classical bi;dimensional culture systems challenged with polyethylene 
particles 
(20)
. Indeed, this model allowed the homogenous exposition of nanoparticles to adherent 
macrophages/osteoclasts, avoiding the physical separation between particles (floating in the top 
of culture media) and cells (bottom of the well) 
(20),(21)
. The fluorescence property of 
nanoparticles enabled efficient detection and straightforward follow;up using routine methods. In 
addition, MFI value was an original parameter to semi;quantify the fluorescent intensity of 
nanoparticles uptaken by macrophages. This method is then a cost;effective and reliable way to 
assess the nanoparticle traffic in monocyte;derived cell cultures.  
 
We next confirmed the intracellular location of FPN in both macrophages and osteoclasts, using 
confocal and video time;lapse microscopy. After quick internalization by macrophages (20 
minutes), FPN were aggregated in small and large clusters and appear to be enveloped by a 
membrane;like structure. From 1 hour to 48 hours, macrophages randomly exocytosed a less 
fluorescent and clustered nanoparticles to the extracellular media continuously limited by a 
membrane;like structure. Following this process, some macrophages modified their morphology, 
lost their attachment and died. Interestingly, osteoclast precursors and mature osteoclasts also 
internalized nanoparticles, clustering and dissociating them in their intracellular compartment. 
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These findings could be related by the common hematopoietic/mononuclear cell origin of both 
macrophages and osteoclasts. Thus, their capability to internalize cell debris, micro; and 
nanoparticles are related to a typical feature of phagoctytic cells. Passive endocytosis of 
nanoparticles of 100;200 nm has been also reported in various cell types, including HeLa cells, 
mesenchymal stem cells and osteoblasts 
(22)–(24)
. While the nanoparticle size used in this study 
was 169 ± 77 nm, the methods used in our study did not allow to define the exact mechanism 
underlying their internalization, constituting one of the limitations of the current study.
 
The intracellular dissociation and subsequent clustering of FPN observed in both macrophages 
and osteoclasts, strongly suggests that they were trafficked in the intracellular compartments of 
these cells, presumably by the endolysosomic pathway 
(7),(25),(26)
. In fact, once FPN were 
internalized by macrophages, they were rapidly clustered and limited by membrane;like 
structures and then mobilized from one pole of the cell (internalization pole) to the opposite 
(exocytose pole) followed by the release of the clustered fluorescent bodies in the extracellular 
compartment and cell death. The traffic of nanoparticles in macrophages through endolysosome 
compartment with subsequent cell damages and death, has been previously observed by Maitra 
	(2009) 
(7)
. In fact, these authors associated this trafficking with endosomal damage, cell stress 
and activation of the NALP3 inflammasome 
(7)
. Regarding this mechanism, the involvement of 
Cathepsin B, interleukin (IL) ;1ș and IL;18 and the induction of inflammatory programed cell 
death (pyroptosis) have also been proposed as a mechanism involved in cell death under 
inflammatory environment 
(7),(27),(28)
. 
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 
Finally, osteoclast precursors enhanced osteoclast differentiation   in a dose; and time;
dependent manner after exposition to FPN. The growing upregulation of TRAP expression 
confirm the functional activation induced by internalized FPN on both osteoclast precursors (at 
day 2;6 of exposition) and mature osteoclasts (at day 9 of exposition). However, the number of 
mature osteoclasts only increased when osteoclast precursors were exposed to FPN for at least 4 
days (Figure 2C). While the osteoclastogenesis is mainly promoted by RANKL;producing 
osteoblasts, several stimuli, including LPS 
(29)
, may also up regulate the exacerbated bone 
resorption. In our study, we exclusively induced osteoclastogenesis by adding exogenous 
RANKL to macrophages challenged by LPS;free FPN, in order to exclude a secondary pro;
osteoclastogenic stimulus. On other hand, the observed time;dependent osteoclastogenesis may 
be associated with the reported early activation of both nuclear factor kappa;B (NF;kB) and 
nuclear factor of activated T;cells (NFAT) pathways in osteoclast precursors incubated with 
polymethylmethacrylate (PMMA) particles 
(30),(31)
. These observations are in agreement with 
clinical scenario, where macrophages present in the periprosthetic tissue are exposed to 
cumulative volumes of nano;sized wear particles continuously released from bearing surfaces 
(9),(32)
. We observed a clear difference in the morphology of osteoclasts exposed to FPN with 
maintenance of their resorptive activity. These findings would suggest a reorganization of the 
cytoskeleton attributable to FPN challenge, however the interpretation of them remains limited 
due the qualitative nature of this assessment. Further functional studies are needed to elucidate 
the impact of FPN on the reorganization of cytoskeleton and function.  
   
FPN are internalized by macrophages and are able to promote osteoclast differentiation. An 
assessment of these two key events described in particle;induced inflammation and osteolysis 
will be necessary in pre;clinical animal models 
(33)
. The first objective of   assessment 
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should be to determine if FPN are able to induce inflammatory and osteolytic changes in a bone 
site. To address this subject, the use of the cost;effective calvaria mouse model appears very 
appropriate as a first step. This model allows a quick assessment of both inflammation and 
osteolysis in an orthotopic site 
(33)
. Our group recently reported inflammatory and osteolytic 
changes starting at day 7 after surgical micro;particle (6 m) implantation 
(3)
. On other hand, 
Goodman’s group reported the feasibility to induce osteolysis in the same model by the 
transcutaneous implantation of micro;particle in a smaller range, reducing the potential bias of 
inflammation due to the surgical approach 
(34)
. Based on these reports, it may possible to carry 
out the implantation of these FPN in a bone site by transcutaneous injection. The second step will 
be an infusion of FPN into the epiphysis of a long bone using the continuous infusion femoral 
model, the most clinically relevant mouse model in this field 
(32),(33)
.     
 
In summary, FPN are internalized by macrophages, osteoclast precursors and also by mature 
osteoclasts in a time; and dose;dependent manner. FPN exhibit a pro;osteoclastic effect when 
they were exposed to osteoclast precursors for at least 4 days. Our results strongly suggest that 
polyethylene nano;sized wear particles have a pro;osteoclastogenic effect and identify them as 
potential new actors in the pathogenesis of aseptic loosening of the current generation of 
polyethylene bearing surfaces (Figure 3). Further comparative studies are needed to elucidate the 
relevance of nano;sized wear particles compared with standardized stimulus in cell models of 
aseptic loosening.  



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A) 
Macrophages were incubated with three ratios of FPN per cell for 48 hours. B) Macrophage 
viability (DAPI staining) after FPN exposure for up to 48 hours. C) Kinetic assessment of the 
FPN uptake by macrophages. D) Highly adherent macrophages exhibited clustered FPN in the 
intracellular compartment. E) Clustered FPN were mostly detected in the extracellular media 
rather than in the cytosolic compartment of low adherent macrophages. Both D and E images 
were acquired by confocal microscopy from macrophage cell cultures exposed during 48 hours to 
FPN (7*87467'9	
 Fluorescent polyethylene;like nanoparticles (FPN), Mean Fluorescent intensity (MFI), p < 0.05 
(*), p < 0.01 (**) and p < 0.001 (***). 
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		 !"	 A) FPN were detected in the intracellular 
compartment of both osteoclast precursors at 4 hrs (orthogonal sections, left picture) and 
osteoclasts after 4 hours and 9 days of incubation (orthogonal sections, right pictures) using 
confocal microscopy (7*87467'9. B) 
Osteoclasts were identified by TRAP staining and their activity was detected by scanning 
electron microscopy of the pit resorption assay on dentin slice. C) The number of TRAP
+
 
multinucleated cells (osteoclasts) was quantified at endpoint according to several doses (left 
panel) and time of exposition to FPN (right panel). D) The relative expression of TRAP by 
osteoclasts exposed to FPN at three time points was expressed as fold;change. Fluorescent 
polyethylene;like nanoparticles (FPN), Osteoclast precursors (OCP), Mature osteoclasts (OCs), 
Fold;change (Fc), p < 0.05 (*), p < 0.01 (**), p < 0.001 (***), p < 0.0001 (****).   
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A)AP pelvis x;ray of revised 
right metal;polyethylene THA in a 73;year;old;woman secondary to congenital hip dysplasia. B) 
and C) Zoomed views of 2013 (B) and 2014 (C) AP pelvis x;rays showing the incremental 
radiolucency (osteolysis) around the acetabular component (black arrows) of THA in the same 
patient. Osteolysis is the consequence of cumulative rates of wear debris particles released from 
frictional bearing surfaces of the THA. D) Polarized histological view of the periprosthetic 
interface in an experimental model of polyethylene;particle osteolysis (Córdova LA, 2014). 
Chronic inflammatory response (*) induced by polyethylene wear particles (white arrows), which 
are in close relationship with osteoclast;like cells (translucid arrows) identified on their bone 
resorptive lacunae. 
Antero;posterior (AP), Total Hip Replacement (THA) 
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A) Chemical structure: (E);icosyl 3;(4;(bis(4';(tert;butyl);[1,1';biphenyl];4;yl)amino)phenyl);2;
cyanoacrylate. B) Water;suspended FPN by TEM C) Diameter and dispersivity of FPN by DLS 
Fluorescent polyethylene;like nanoparticles (FPN); Transmission electron microscopy (TEM); 
Dynamic light scattering (DLS). 
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 Macrophages were incubated with FPN at ratio of 4 x 10
3
 nanoparticles per cell 
and then followed by video time;lapse microscopy including one acquisition every 20 minutes 
during 48 hours. Once FPN were internalized, they were trafficked intracellularily and then 
exocytosed to the extracellular media. Some cells dead after exocytosis. Fluorescent 
polyethylene;like nanoparticles (FPN) 

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 Osteoclasts (Ocs) and their precursors (OCP) were incubated with FPN at ratio of 4 x 
10
3
 nanoparticles per cell and then followed by video time;lapse microscopy including one 
acquisition every 10 minutes during 48 hours. Osteoclasts internalize FPN identified by localized 
red fluorescence (white arrow). Otherwise, osteoclast precursors actively internalize FPN, 
keeping them diffusely in the intracellular compartment. Fluorescent polyethylene;like 
nanoparticles (FPN), Osteoclast precursors (OCP), Mature osteoclasts (OCs). 
 
Page 24 of 27
John Wiley & Sons, Inc.
Journal of Biomedical Materials Research: Part A
This article is protected by copyright. All rights reserved.



	
	
 !	"#$%&'
( !	)*+$	&
$
(	,)
$($
	"&,-$$
( !%./.$+.&'	
$$+%.$%'.01	12%3.01	1
%3301	11%333	
42 (51%611(611&'


Page 25 of 27
John Wiley & Sons, Inc.
Journal of Biomedical Materials Research: Part A
This article is protected by copyright. All rights reserved.



	


	
 
!"#  !$ 
"# "#
%&#
'#(
)	*+ 

& 	,
 
-". &
"  
"	(& 


 /	/'
"
#+"+,
#0"+,#/"#12	23"4#
12	25"44#12	225"444#12	2225"4444	
5$23!"622622(
)
Page 26 of 27
John Wiley & Sons, Inc.
Journal of Biomedical Materials Research: Part A
This article is protected by copyright. All rights reserved.
  
 
 
	

  !"#$%
 
 
Page 28 of 27
John Wiley & Sons, Inc.
Journal of Biomedical Materials Research: Part A
This article is protected by copyright. All rights reserved.
